Develop the next generation of T-cell therapies for patients with pediatric brain tumors by targeting tumor cells in a more precise, safer, and accelerated fashion. The goal is to expedite research and lay the groundwork for a clinical trial.
DatesJan 1, 2020 – Dec 31, 2020